Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Health Canada has granted conditional approval to Gilead Sciences’ remdesivir (Veklury) to treat patients with severe Covid-19 who have pneumonia and need oxygen support.
Remdesivir is the first drug authorised in the country for Covid-19 treatment. It can be used in adults and adolescents aged 12 years and above with a minimum body weight of 40kg.
The company did not seek approval for use in children or pregnant women. In a statement, Health Canada said: “The Department has approved this drug with conditions for the manufacturer to ensure the continued safety, efficacy and quality of the drug. “Remdesivir is administered.